PhD Scientific Days 2023

Budapest, 22-23 June 2023

Pharmaceutical Sciences - Posters F

Cardiovascular safety of SGLT2i and GLP-1RA combination therapy: disproportionality analysis of the FDA adverse event reporting system

Eszter Puhl1, Mátyás Pétervári1, Olivér Balogh1, Szandra Marton1, Bence Ágg1,2, Péter Ferdinandy1,2

1Cardiometabolic and MTA-SE System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary
2Pharmahungary Group, Szeged, Hungary